GELESIS HOLDINGS INC (GLS) Stock Overview
NYSE:GLS - US36850R2040 - Common Stock
GLS Key Statistics, Chart & Performance
The current stock price of GLS is 0.1586 USD. In the past month the price decreased by -33.92%. In the past year, price decreased by -96.82%.
GLS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.89 | 372.04B | ||
| AMGN | AMGEN INC | 13.47 | 158.13B | ||
| GILD | GILEAD SCIENCES INC | 14.83 | 142.41B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.32 | 101.30B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.92 | 62.48B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.56B | ||
| ARGX | ARGENX SE - ADR | 71.2 | 40.39B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.35 | 37.29B | ||
| INSM | INSMED INC | N/A | 27.88B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.66B | ||
| NTRA | NATERA INC | N/A | 22.73B | ||
| BIIB | BIOGEN INC | 8.7 | 20.42B |
Related stock screener links
About GLS
Company Profile
Gelesis Holdings, Inc. operates as a biotechnology company. The company is headquartered in Boston, Massachusetts and currently employs 93 full-time employees. The company went IPO on 2020-07-07. The firm focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. The company is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of FC.
Company Info
GELESIS HOLDINGS INC
501 Boylston Street, Suite 6102
Boston MASSACHUSETTS US
Employees: 93
Phone: 18573277737.0
GELESIS HOLDINGS INC / GLS FAQ
What is the stock price of GELESIS HOLDINGS INC today?
The current stock price of GLS is 0.1586 USD. The price increased by 0.38% in the last trading session.
What is the ticker symbol for GELESIS HOLDINGS INC stock?
The exchange symbol of GELESIS HOLDINGS INC is GLS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is GLS stock listed?
GLS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for GELESIS HOLDINGS INC stock?
8 analysts have analysed GLS and the average price target is 0.46 USD. This implies a price increase of 189.41% is expected in the next year compared to the current price of 0.1586. Check the GELESIS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GELESIS HOLDINGS INC worth?
GELESIS HOLDINGS INC (GLS) has a market capitalization of 11.63M USD. This makes GLS a Nano Cap stock.
How many employees does GELESIS HOLDINGS INC have?
GELESIS HOLDINGS INC (GLS) currently has 93 employees.
What are the support and resistance levels for GELESIS HOLDINGS INC (GLS) stock?
GELESIS HOLDINGS INC (GLS) has a resistance level at 0.17. Check the full technical report for a detailed analysis of GLS support and resistance levels.
Is GELESIS HOLDINGS INC (GLS) expected to grow?
The Revenue of GELESIS HOLDINGS INC (GLS) is expected to grow by 80.41% in the next year. Check the estimates tab for more information on the GLS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GELESIS HOLDINGS INC (GLS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GLS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GLS, evaluating the profitability, health, valuation and growth aspects
- GELESIS HOLDINGS INC (GLS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GELESIS HOLDINGS INC (GLS) Sales and EPS estimates to see what analysts future expectations are.
- GELESIS HOLDINGS INC (GLS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GELESIS HOLDINGS INC (GLS) Insider and Institutional Ownership to learn about the owners and their transactions.
- GELESIS HOLDINGS INC (GLS) Stock Chart to make your own analysis
- GELESIS HOLDINGS INC (GLS) Latest news and press-releases to stay up to date.
Does GELESIS HOLDINGS INC (GLS) stock pay dividends?
GLS does not pay a dividend.
When does GELESIS HOLDINGS INC (GLS) report earnings?
GELESIS HOLDINGS INC (GLS) will report earnings on 2023-05-10, before the market open.
What is the Price/Earnings (PE) ratio of GELESIS HOLDINGS INC (GLS)?
GELESIS HOLDINGS INC (GLS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.31).
GLS Technical Analysis
GLS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GLS. GLS may be in some trouble as it scores bad on both profitability and health.
GLS Financial Highlights
Over the last trailing twelve months GLS reported a non-GAAP Earnings per Share(EPS) of -1.31. The EPS increased by 66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GLS Forecast & Estimates
8 analysts have analysed GLS and the average price target is 0.46 USD. This implies a price increase of 189.41% is expected in the next year compared to the current price of 0.1586.
For the next year, analysts expect an EPS growth of 78.59% and a revenue growth 80.41% for GLS